Suppr超能文献

帕金森病非人灵长类MPTP模型中的移植:最新进展与展望

Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives.

作者信息

Wianny Florence, Vezoli Julien

机构信息

Univ Lyon, Université Claude Bernard Lyon 1, Inserm, Stem Cell and Brain Research Institute U1208, 69500 Bron, France.

Ernst Strüngmann Institute (ESI) for Neuroscience in Cooperation with Max Planck Society, 60528 Frankfurt, Germany.

出版信息

Primate Biol. 2017 Oct 11;4(2):185-213. doi: 10.5194/pb-4-185-2017. eCollection 2017.

Abstract

In order to calibrate stem cell exploitation for cellular therapy in neurodegenerative diseases, fundamental and preclinical research in NHP (nonhuman primate) models is crucial. Indeed, it is consensually recognized that it is not possible to directly extrapolate results obtained in rodent models to human patients. A large diversity of neurological pathologies should benefit from cellular therapy based on neural differentiation of stem cells. In the context of this special issue of Primate Biology on NHP stem cells, we describe past and recent advances on cell replacement in the NHP model of Parkinson's disease (PD). From the different grafting procedures to the various cell types transplanted, we review here diverse approaches for cell-replacement therapy and their related therapeutic potential on behavior and function in the NHP model of PD.

摘要

为了校准干细胞在神经退行性疾病细胞治疗中的应用,在非人类灵长类动物(NHP)模型中进行基础和临床前研究至关重要。事实上,人们普遍认为,不可能将在啮齿动物模型中获得的结果直接外推到人类患者身上。多种神经病理学疾病应能从基于干细胞神经分化的细胞治疗中受益。在《灵长类生物学》关于NHP干细胞的这一特刊中,我们描述了帕金森病(PD)NHP模型中细胞替代的过去和近期进展。从不同的移植程序到移植的各种细胞类型,我们在此回顾了细胞替代疗法的多种方法及其在PD NHP模型中对行为和功能的相关治疗潜力。

相似文献

1
Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives.
Primate Biol. 2017 Oct 11;4(2):185-213. doi: 10.5194/pb-4-185-2017. eCollection 2017.
3
Stem cell therapy for Parkinson's disease using non-human primate models.
Zool Res. 2019 Sep 18;40(5):349-357. doi: 10.24272/j.issn.2095-8137.2019.053.
6
Nonhuman primate model in clinical modeling of diseases for stem cell therapy.
Brain Circ. 2016 Jul-Sep;2(3):141-145. doi: 10.4103/2394-8108.192524. Epub 2016 Oct 18.
7
Nonhuman primate models of Parkinson's disease.
ILAR J. 2007;48(4):339-55. doi: 10.1093/ilar.48.4.339.
8
The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.
J Neural Transm (Vienna). 2018 Mar;125(3):365-384. doi: 10.1007/s00702-017-1708-9. Epub 2017 Mar 22.
9
Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease.
Stem Cell Res. 2016 Sep;17(2):352-366. doi: 10.1016/j.scr.2016.08.013. Epub 2016 Aug 26.
10
The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future.
Prog Brain Res. 2010;184:133-57. doi: 10.1016/S0079-6123(10)84007-5.

引用本文的文献

1
Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson's disease in animal models.
NPJ Parkinsons Dis. 2022 Dec 22;8(1):175. doi: 10.1038/s41531-022-00440-6.
2
Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease.
NPJ Regen Med. 2022 Apr 21;7(1):24. doi: 10.1038/s41536-022-00221-y.
4
Modeling Parkinson's Disease: Not Only Rodents?
Front Aging Neurosci. 2021 Aug 6;13:695718. doi: 10.3389/fnagi.2021.695718. eCollection 2021.

本文引用的文献

1
Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).
Prog Brain Res. 2017;230:165-190. doi: 10.1016/bs.pbr.2016.11.011. Epub 2017 Feb 7.
2
Biomaterials and cells for neural tissue engineering: Current choices.
Mater Sci Eng C Mater Biol Appl. 2017 Aug 1;77:1302-1315. doi: 10.1016/j.msec.2017.03.264. Epub 2017 Mar 30.
3
α-Synuclein nonhuman primate models of Parkinson's disease.
J Neural Transm (Vienna). 2018 Mar;125(3):385-400. doi: 10.1007/s00702-017-1720-0. Epub 2017 Apr 22.
5
Detecting senescence: a new method for an old pigment.
Aging Cell. 2017 Jun;16(3):432-434. doi: 10.1111/acel.12580. Epub 2017 Feb 9.
6
Differential behavioral outcomes following neonatal versus fetal human retinal pigment epithelial cell striatal implants in parkinsonian rats.
J Neural Transm (Vienna). 2017 Apr;124(4):455-462. doi: 10.1007/s00702-017-1683-1. Epub 2017 Feb 4.
7
Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease.
Cell Stem Cell. 2017 Jan 5;20(1):135-148. doi: 10.1016/j.stem.2016.09.004. Epub 2016 Oct 27.
8
Parkinson's Disease and Cognitive Impairment.
Parkinsons Dis. 2016;2016:6734678. doi: 10.1155/2016/6734678. Epub 2016 Dec 12.
9
Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells.
Cell. 2016 Oct 6;167(2):566-580.e19. doi: 10.1016/j.cell.2016.09.027.
10
Development of Bioresorbable Hydrophilic-Hydrophobic Electrospun Scaffolds for Neural Tissue Engineering.
Biomacromolecules. 2016 Oct 10;17(10):3172-3187. doi: 10.1021/acs.biomac.6b00820. Epub 2016 Sep 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验